209 related articles for article (PubMed ID: 34587434)
1. A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets.
Wu S; Zang Q; Xing Z; Li X; Leng J; Liu Y; Wang X; Yang J
Crit Rev Eukaryot Gene Expr; 2021; 31(4):35-48. PubMed ID: 34587434
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of prognostic value and immune infiltration of IAPs family in hepatocellular carcinoma.
Yang X; Yu X; Nie H; Jiang W; Zhou J; Ou C; He X
J Cancer; 2023; 14(15):2848-2866. PubMed ID: 37781078
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of apoptotic proteins: new targets for anticancer therapy.
Saleem M; Qadir MI; Perveen N; Ahmad B; Saleem U; Irshad T; Ahmad B
Chem Biol Drug Des; 2013 Sep; 82(3):243-51. PubMed ID: 23790005
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of the
Lee MK; Noh JK; Woo SR; Kong M; Lee YC; Lee JW; Ko SG; Eun YG
Cancer Genomics Proteomics; 2022; 19(5):591-605. PubMed ID: 35985688
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.
Smolewski P; Robak T
Curr Mol Med; 2011 Nov; 11(8):633-49. PubMed ID: 21902653
[TBL] [Abstract][Full Text] [Related]
7. Baculoviral inhibitors of apoptosis repeat containing (BIRC) proteins fine-tune TNF-induced nuclear factor κB and c-Jun N-terminal kinase signalling in mouse pancreatic beta cells.
Tan BM; Zammit NW; Yam AO; Slattery R; Walters SN; Malle E; Grey ST
Diabetologia; 2013 Mar; 56(3):520-32. PubMed ID: 23250032
[TBL] [Abstract][Full Text] [Related]
8. Increased Expression of
Gil-Kulik P; Świstowska M; Kondracka A; Chomik P; Krzyżanowski A; Kwaśniewska A; Rahnama M; Kocki J
Oxid Med Cell Longev; 2020; 2020():9084730. PubMed ID: 32322338
[TBL] [Abstract][Full Text] [Related]
9. A pan-cancer study of class-3 semaphorins as therapeutic targets in cancer.
Zhang X; Klamer B; Li J; Fernandez S; Li L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):45. PubMed ID: 32241267
[TBL] [Abstract][Full Text] [Related]
10. Influence of Perinatal Factors on Gene Expression of IAPs Family and Main Factors of Pluripotency:
Gil-Kulik P; Leśniewski M; Bieńko K; Wójcik M; Więckowska M; Przywara D; Petniak A; Kondracka A; Świstowska M; Szymanowski R; Wilińska A; Wiliński M; Płachno BJ; Kostuch M; Rahnama-Hezavach M; Szuta M; Kwaśniewska A; Bogucka-Kocka A; Kocki J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768802
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of BIRC2 and BIRC3 expression by inflammatory cytokines and glucocorticoids in pulmonary epithelial cells.
Thorne A; Bansal A; Necker-Brown A; Mostafa MM; Gao A; Georgescu A; Kooi C; Leigh R; Newton R
PLoS One; 2023; 18(6):e0286783. PubMed ID: 37289679
[TBL] [Abstract][Full Text] [Related]
12. High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer.
Yang Y; Sun P; Xu W; Xia W
Technol Cancer Res Treat; 2018 Jan; 17():1533033818809694. PubMed ID: 30376767
[TBL] [Abstract][Full Text] [Related]
13. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.
Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z
Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485
[TBL] [Abstract][Full Text] [Related]
14. BIRC3 and BIRC5: multi-faceted inhibitors in cancer.
Frazzi R
Cell Biosci; 2021 Jan; 11(1):8. PubMed ID: 33413657
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive molecular characterization of inhibitors of apoptosis proteins (IAPs) for therapeutic targeting in cancer.
Liang J; Zhao W; Tong P; Li P; Zhao Y; Li H; Liang J
BMC Med Genomics; 2020 Jan; 13(1):7. PubMed ID: 31964418
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.
Gressot LV; Doucette T; Yang Y; Fuller GN; Manyam G; Rao A; Latha K; Rao G
Oncotarget; 2017 Feb; 8(8):12695-12704. PubMed ID: 27074575
[TBL] [Abstract][Full Text] [Related]
17. A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Yang X; Miao Y; Wang J; Mi D
Life Sci; 2021 May; 273():119307. PubMed ID: 33691171
[TBL] [Abstract][Full Text] [Related]
18. Gene network revealed involvements of Birc2, Birc3 and Tnfrsf1a in anti-apoptosis of injured peripheral nerves.
Wang Y; Tang X; Yu B; Gu Y; Yuan Y; Yao D; Ding F; Gu X
PLoS One; 2012; 7(9):e43436. PubMed ID: 23028454
[TBL] [Abstract][Full Text] [Related]
19. The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis.
Luk SU; Xue H; Cheng H; Lin D; Gout PW; Fazli L; Collins CC; Gleave ME; Wang Y
Oncotarget; 2014 Aug; 5(16):6896-908. PubMed ID: 25071009
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect.
Han X; Ye J; Huang R; Li Y; Liu J; Meng T; Song D
Front Immunol; 2022; 13():900273. PubMed ID: 36159856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
